Academic Journal
Q1Nature Reviews Neurology
About Nature Reviews Neurology
Nature Reviews Neurology is a scholarly journal published by Nature Research. SCImago 2025 places it in Q1 with an SJR of 7.083 and an H-index of 244.
Its listed coverage is 2009-2026 and its research categories include Cellular and Molecular Neuroscience (Q1); Neurology (clinical) (Q1). The 2025 dataset reports 122 documents and 5581 citations across the latest three-year reporting window.
Nature Reviews Neurology is one of the most respected and widely cited journals in the field of neurology. Published by Springer Nature, this prestigious journal delivers high-impact, peer-reviewed review articles that provide expert insights into the latest advances in neurological science and clinical practice. It serves as an invaluable resource for neurologists, neuroscientists, and healthcare professionals worldwide who are dedicated to understanding and treating disorders of the nervous system.
Comprehensive Coverage of Neurological Topics
Nature Reviews Neurology offers broad and in-depth coverage of a wide range of neurological disorders, including but not limited to:
-
Alzheimer's disease and other dementias
-
Parkinson’s disease and movement disorders
-
Stroke and cerebrovascular disorders
-
Multiple sclerosis and autoimmune neurological diseases
-
Epilepsy and seizure disorders
-
Neuromuscular diseases
-
Headache and pain syndromes
-
Pediatric and developmental neurology
Each issue includes expert-written, evidence-based review articles, opinion pieces, and commentaries that keep readers at the forefront of clinical research and neurological advancements. The content is carefully curated to bridge the gap between cutting-edge research and clinical application.
Trusted by the Global Neurology Community
With an impressive impact factor and a rigorous peer-review process, Nature Reviews Neurology is consistently ranked among the top journals in clinical neurology. Its articles are widely cited in academic literature and often influence clinical guidelines and healthcare policy. Researchers, clinicians, and medical educators rely on its high-quality content to stay informed and deliver the best care to patients.
The journal also features perspectives from world-renowned experts in neurology, providing readers with authoritative insights into controversial topics, emerging therapies, and translational research. This makes Nature Reviews Neurology not only a scientific publication but a platform for thought leadership in neurological medicine.
A Valuable Tool for SEO and Academic Visibility
For academics and institutions, publishing in Nature Reviews Neurology can significantly boost visibility, citation metrics, and research impact. As the journal is indexed in major databases such as PubMed, Scopus, and Web of Science, articles published in it are easily discoverable by a global audience. Its SEO-friendly structure ensures that readers searching for the latest in neurology—be it treatment guidelines for multiple sclerosis or the genetic basis of epilepsy—can quickly find relevant, trustworthy content.
Digital Accessibility and Global Reach
Nature Reviews Neurology is available both in print and online, offering researchers and clinicians the convenience of accessing content from anywhere in the world. Its website is optimized for mobile and desktop, making it easy to search for articles, browse topics, and stay up to date with current issues and trends.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
Nature Reviews Neurology is a leading peer-reviewed journal that delivers authoritative, high-impact reviews and perspectives in the field of neurology. As part of the prestigious Nature Portfolio, the journal serves as a vital resource for clinicians, researchers, and healthcare professionals who seek the most current and clinically relevant developments in neurological science. Its broad scope, rigorous editorial standards, and expert authorship make it one of the most respected and widely read publications in the neurology community.
Comprehensive Coverage of Neurological Disorders
The scope of Nature Reviews Neurology encompasses a wide range of neurological diseases and disorders, including but not limited to Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, epilepsy, stroke, migraine, amyotrophic lateral sclerosis (ALS), neuroinflammatory conditions, and rare neurological syndromes. The journal also explores neurodevelopmental and neurodegenerative diseases, offering insights into their underlying mechanisms, clinical manifestations, diagnostic approaches, and treatment strategies.
Each article is designed to provide a balanced, accessible, and up-to-date summary of complex topics, integrating both established knowledge and emerging discoveries. Whether focusing on molecular pathways, novel therapeutic interventions, or advancements in neuroimaging, the journal aims to bridge the gap between research and clinical practice.
Focus on Translational and Clinical Neurology
A key strength of Nature Reviews Neurology lies in its emphasis on translational medicine. The journal prioritizes content that connects basic research findings to clinical applications, enabling neurologists and neuroscientists to stay informed about innovations that may soon impact patient care.
Articles often include discussions on clinical trials, biomarker development, precision medicine, and evolving treatment guidelines. This focus ensures that healthcare providers are equipped with the latest evidence-based knowledge to enhance diagnostic accuracy and improve patient outcomes.
Expert-Driven Content and Editorial Integrity
All content published in Nature Reviews Neurology is written by internationally recognized experts and undergoes a rigorous peer-review process. The journal’s editorial team works closely with authors to ensure clarity, accuracy, and relevance. Articles are richly illustrated, often featuring high-quality figures, tables, and diagrams that support comprehension and clinical utility.
The journal publishes a mix of review articles, perspectives, commentaries, and editorials, all curated to stimulate thought, inspire new research directions, and encourage interdisciplinary collaboration in neurology.
A Trusted Source for Continuing Education
For medical professionals and academics alike, Nature Reviews Neurology serves as an essential tool for continuing education. With its consistent publication of authoritative, well-researched content, the journal supports the lifelong learning needs of neurologists, neurosurgeons, neuroscientists, and allied health professionals.
Recent Research Articles
Latest publications matched automatically by ISSN.
Cortical lesions in multiple sclerosis: 25 years of progress, remaining challenges and future directions
Massimiliano Calabrese, Roberta Magliozzi, Agnese Tamanti, Stefano Ziccardi et al.
2026-09-07 · DOI: 10.1038/s41582-026-01263-2Role of complement and complement-targeted therapeutics in neurological diseases
Marinos C. Dalakas, Jan D. Lünemann
2026-09-03 · DOI: 10.1038/s41582-026-01261-4Effects of obesity on brain health and cognition
Cali M. McEntee, Masha G. Savelieff, Mohamed H. Noureldein, Stephanie A. Eid et al.
2026-09-01 · DOI: 10.1038/s41582-026-01251-6Symptomatic treatment for Alzheimer disease: current evidence and future directions
Clive Ballard, Pat Doherty, Zahinoor Ismail, Anne Corbett et al.
2026-09-01 · DOI: 10.1038/s41582-026-01260-5Reverse electron transport connects tauopathy to mitochondrial dysfunction
Heather Wood
2026-08-27 · DOI: 10.1038/s41582-026-01265-0Complex regional diversity in synucleinopathies
Ian Fyfe
2026-09 · DOI: 10.1038/s41582-026-01256-1Shared mechanism of mutagenesis in neurodegeneration
Ian Fyfe
2026-09 · DOI: 10.1038/s41582-026-01257-0Circular RNAs outperform established Alzheimer disease biomarkers
Ian Fyfe
2026-09 · DOI: 10.1038/s41582-026-01259-yBrain asymmetry patterns associated with age-related disease
Ian Fyfe
2026-09 · DOI: 10.1038/s41582-026-01258-zMenopause and neurological disorders: a roadmap for research
Riley Bove, Ruth Dobson
2026-09 · DOI: 10.1038/s41582-026-01244-5Tumour and microenvironment targeting of glioblastoma with dual-acting CAR T cells
Lisa Kiani
2026-09 · DOI: 10.1038/s41582-026-01254-3Losing sleep over glia: new mechanisms for Alzheimer-related sleep disruption
Brendan P. Lucey, Michael J. Howell
2026-08-04 · DOI: 10.1038/s41582-026-01255-2Towards a biologically informed description of multiple sclerosis disease course — a roadmap for transition
Alan J. Thompson, Fred D. Lublin, Lindsay Rechtman, James Quinn et al.
2026-08-03 · DOI: 10.1038/s41582-026-01249-0White matter disorders at the intersection of transcription, RNA processing and translation
Alexandra Chapleau, Felipe Villa Tobón, Geneviève Bernard
2026-08-03 · DOI: 10.1038/s41582-026-01248-1Reply to ‘Low-field MRI for equitable epilepsy diagnosis in resource-limited settings’
Tavia E. Evans, Joshua Harper, Aram Salehi, Andrew G. Webb et al.
2026-07-29 · DOI: 10.1038/s41582-026-01253-4Low-field MRI for equitable epilepsy diagnosis in resource-limited settings
Melody T. Asukile, Josemir W. Sander, John S. Duncan
2026-07-29 · DOI: 10.1038/s41582-026-01252-5Newborn screening is the missing step in spinal muscular atrophy care
Jesy Nelson, Giles Lomax
2026-09 · DOI: 10.1038/s41582-026-01250-7Brain-first and body-first subtypes of Lewy body disease
Per Borghammer, Nathalie Van Den Berge, Daniela Berg, Ryosuke Takahashi et al.
2026-09 · DOI: 10.1038/s41582-026-01241-8Neurological symptoms in survivors of Ebola virus disease
Lisa Kiani
2026-08 · DOI: 10.1038/s41582-026-01247-2Chromosome 21 gene DSCAM drives Down syndrome phenotypes
Lisa Kiani
2026-08 · DOI: 10.1038/s41582-026-01246-3Reviews
Community Reviews
Version History
April 19, 2025 at 5:28 pm
April 19, 2025